Cognition in Chronic Kidney Disease: A Delphi study to identify stakeholder perspectives on relevant research priorities – Round 2

Study Lead

Dr. Clara Bohm

University of Manitoba


Recently, we sent out a survey asking people living with Chronic Kidney Disease, their family members, clinicians, and decision makers, to send us questions regarding cognition in Chronic Kidney Disease that they think are important for future research to address.

Cognition (the ability to remember, learn new things, focus, and/or make everyday life decisions) has been identified as a top research priority for people with Chronic Kidney Disease.

Our research team has organized all the questions into 10 broad categories. In Round 2 of this survey, we are inviting you to rank each of the questions on a scale of 1-9, based on how important you think each question is for future research to address.

There are no right or wrong and answers. Further information can be found in the Research Participant Information and Consent Statement.

This survey is voluntary, and all responses will be kept secure; responses will be stripped of email addresses prior to analyses. Your participation will involve completing three survey rounds to reach consensus – this is the second round of the survey. Each round will take approximately 10-15 minutes to complete.  All participants who complete the surveys will receive a report of the final results.

Completing the survey implies that you have consented to participate.

If you have any questions about the research now or later, please contact the Principal Investigator, Dr. Clara Bohm at or the Research Coordinator, Oksana Harasemiw at or 1-204-632-3541.

You may open the survey in your web browser by clicking the link below:

Thank you in advance for your participation.


Dr. Clara Bohm and the Study Team
On behalf of the Global Renal Exercise Network

Type of Participation



Chronic Kidney Disease


Quality of Life, Symptoms


All provinces and territories

Related studies

  • Take part in one hemodialysis session to evaluate Qidni Labs’ nearly waterless and portable dialysis system

    Overview: Qidni Labs is inviting up to 30 patients with kidney failure to take part in research studying the “Qidni/D”, an investigational hemodialysis device, as a possible treatment for kidney failure.

    Study type: Clinical Trial

    May 16, 2023

  • Person-centered integrated care delivery for patients with chronic kidney disease and multimorbidity in the primary care setting and primary-nephrology care interface

    Overview: Participants are invited to complete a 15-minute survey with questions about their experience with kidney care in Alberta.

    Study type: Survey

    May 16, 2023

  • Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease (ACHIEVE)

    Overview: The purpose of this study is to determine if spironolactone reduces death or hospitalization for heart failure and is well tolerated in patients that require dialysis.

    Study type: Clinical Trial

    April 28, 2023